BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 952259)

  • 1. Sinus bradycardia and atrial fibrillation associated with the Wolff-Parkinson-White syndrome.
    Dreifus LS; Wellens HJ; Watanabe Y; Kimbiris D; Truex R
    Am J Cardiol; 1976 Aug; 38(2):149-56. PubMed ID: 952259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
    Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
    J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac vulnerability.
    Surawicz B; Steffens T
    Cardiovasc Clin; 1973; 5(3):159-81. PubMed ID: 4601967
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.
    Waspe LE; Brodman R; Kim SG; Fisher JD
    Am Heart J; 1986 Dec; 112(6):1141-52. PubMed ID: 3788760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern.
    Milstein S; Sharma AD; Klein GJ
    Am J Cardiol; 1986 May; 57(13):1097-100. PubMed ID: 3706161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
    Favale S; Minafra F; Massari V; Tritto M; Rizzon P
    Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of atrial fibrillation and atrioventricular conduction (including Wolff-Parkinson-White syndrome) in sudden death.
    Meijler FL; van der Tweel I; Herbschleb JN; Hauer RN; Robles de Medina EO
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):17B-22B. PubMed ID: 3998333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
    CenturiĆ³n OA; Shimizu A; Isomoto S; Konoe A
    Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
    Duckeck W; Kuck KH
    Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation.
    Wellens HJ; Durrer D
    Am J Cardiol; 1974 Dec; 34(7):777-82. PubMed ID: 4432808
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial fibrillation triggered by postinfarction ventricular premature beats in a patient with Wolff-Parkinson-White syndrome.
    Peinado R; Merino JL; Gnoatto M; Arias MA
    Europace; 2005 May; 7(3):221-4. PubMed ID: 15878558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial electrophysiologic abnormalities in patients with Wolff-Parkinson-White syndrome but without paroxysmal atrial fibrillation.
    Sakabe K; Fukuda N; Nada T; Shinohara H; Tamura Y; Wakatsuki T; Nishikado A; Oki T
    Clin Cardiol; 2004 Jul; 27(7):396-400. PubMed ID: 15298039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: comparison with paroxysmal atrial fibrillation alone.
    Gondo N; Kumagai K; Matsuo K; Annoura M; Moroe K; Arakawa K
    Cardiology; 1994; 84(4-5):292-7. PubMed ID: 8187115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic testing in the management of patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
    Morady F; Sledge C; Shen E; Sung RJ; Gonzales R; Scheinman MM
    Am J Cardiol; 1983 Jun; 51(10):1623-8. PubMed ID: 6858868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
    Inoue H; Zipes DP
    Circulation; 1987 Sep; 76(3):637-47. PubMed ID: 3621524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.
    Sellers TD; Bashore TM; Gallagher JJ
    Circulation; 1977 Aug; 56(2):260-7. PubMed ID: 872319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
    Klein GJ; Bashore TM; Sellers TD; Pritchett EL; Smith WM; Gallagher JJ
    N Engl J Med; 1979 Nov; 301(20):1080-5. PubMed ID: 492252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
    Morady F; DiCarlo LA; Baerman JM; De Buitleir M
    Pacing Clin Electrophysiol; 1987 May; 10(3 Pt 1):492-6. PubMed ID: 2439997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
    Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors regulating ventricular rates during atrial flutter and fibrillation in pre-excitation (Wolff-Parkinson-White) syndrome.
    Castellanos A; Myerburg RJ; Craparo K; Befeler B; Agha AS
    Br Heart J; 1973 Aug; 35(8):811-6. PubMed ID: 4729838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.